MedTrace Logo

Cardiovascular Impairments and Obstructive Sleep Apnea Syndrome

NCT01089257 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2025-12-29

No results posted yet for this study

Summary

Which are the anthropometric parameters and/or of severity of the syndrome of apnea of sleep (SAS) which make it possible to anticipate occurred of vascular anomalies, anatomical and/or functional precociously found among patients SAS? Secondary objectives:

1. Which are the anthropometric parameters and/or of severity of SAS allowing to anticipate occurred of early of the cardiac function and/or rhythmic anomalies found among patients SAS?
2. Do there exist biological markers who allow to anticipate the early vascular lesions or the anomalies beginners of the cardiac function?
3. Which are the cardiovascular effects of a treatment of SAS by Continuous Positive Pressure (PC) after 3 to 6 months of treatment?
4. Do the identified early cardiovascular attacks and/or the biological anomalies make it possible to predict occurred of cardiovascular events in this population of patients carrying SAS (followed longitudinal at 5 years)?

Conditions

  • Subclinical Cardiovascular Impairments
  • Obstructive Sleep Apnea Syndrome

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • Hôpital de la Croix-Rousse

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Jean-Louis JP PEPIN, ProfessorPhD · University Hospital, Grenoble

Eligibility

Min Age
18 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2012-11-30
Completion
2021-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01089257 on ClinicalTrials.gov